Ravi Murthy
机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0003-1395-3890
发表论文 256 篇 · 总被引 10642 次 · h-index 54
代表论文
- Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi -NT in Patients with Advanced Solid Tumors (2025 · Clinical Cancer Research · 被引 8)
- Potentiating intratumoral therapy with immune checkpoint inhibitors: shifting the paradigm of multimodality therapeutics (2024 · Immuno-Oncology Technology · 被引 8)
- A Sticky Situation: Glue Migration during Hepatic Vein Embolization (2023 · Seminars in Interventional Radiology · 被引 3)
- A phase Ib study of endogenous T cell therapy using SLC45A2-specific CD8 T cells for patients with metastatic uveal melanoma. (2023 · Journal of Clinical Oncology · 被引 3)
- Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study (2026 · Cancer Discovery)
- Abstract C065: Research biopsy participation and safety in cancer therapeutic trials (2025 · Molecular Cancer Therapeutics)